People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Uptake Medical Corp | — | Biotechnology | Series C | $113.2M | $98.2M | 2011 |
| Stasys Medical Corp. | — | Biotechnology | Seed | $1.4M | $55.6M | 2015 |
Robert Barry at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Barry on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Brooks | 1 | 8 |
| Eric Kim | 1 | 7 |
| Scott Huennekens | 1 | 7 |
| Andrew Schiff | 1 | 5 |
| Michael Hoey | 1 | 4 |
| Carl Simpson | 1 | 4 |
| J.C. MacRae | 1 | 3 |
| Geoff Brooke | 1 | 2 |
| Chris Igielski | 1 | 2 |
| Nathan White | 1 | 2 |
| Linden Rhoads | 1 | 2 |
| R. King Nelson | 1 | 2 |
| Robert King Kuhling | 1 | 1 |
| Sami King Sindi | 1 | 1 |
| Carl King Simson | 1 | 1 |
| Michael Rackley | 1 | 1 |
| Mark Dye | 1 | 1 |
| Sami Sindi | 1 | 1 |
| Robert L. Kuhling, Jr. | 1 | 1 |
| Robert L. Barry | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.